Authors:
Sileni, VC
Nortilli, R
Aversa, SML
Paccagnella, A
Medici, M
Corti, L
Favaretto, AG
Cetto, GL
Monfardini, S
Citation: Vc. Sileni et al., Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients, MELANOMA RE, 11(2), 2001, pp. 189-196
Authors:
Bonetti, A
Zaninelli, M
Leone, R
Franceschi, T
Fraccon, AP
Pasini, F
Sabbioni, R
Cetto, GL
Sich, D
Brienza, S
Howell, SB
Citation: A. Bonetti et al., Use of the ratio of time to progression following first- and second-line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinoma, ANN ONCOL, 12(2), 2001, pp. 187-191
Authors:
Molino, A
Pavarana, M
Micciolo, R
Nortilli, R
Pedersini, R
Manno, P
Bozzi, P
Bonetti, F
Piubello, Q
Cetto, GL
Citation: A. Molino et al., Comparative study of clinical, pathological and biological characteristicsof symptomatic versus asymptomatic breast cancers, ANN ONCOL, 11(5), 2000, pp. 581-586
Authors:
Lippe, P
Tummarello, D
Monterubbianesi, MC
Silva, RR
Giuliodori, L
Mari, D
Santo, A
Pasini, E
Cetto, GL
Rossi, D
Porfiri, E
Cascinu, S
Cellerino, R
Citation: P. Lippe et al., Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: Aphase II study, ANN ONCOL, 10(2), 1999, pp. 217-221
Authors:
Pelosi, G
Pasini, F
Ottensmeier, C
Pavanel, F
Bresaola, E
Bonetti, A
Fraggetta, F
Terzi, A
Iannucci, A
Cetto, GL
Citation: G. Pelosi et al., Immunocytochemical assessment of bone marrow aspirates for monitoring response to chemotherapy in small-cell lung cancer patients, BR J CANC, 81(7), 1999, pp. 1213-1221